Epoch Investment Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328M Buy
1,506,142
+151,894
+11% +$33.7M 1.98% 2
2025
Q4
$309M Sell
1,354,248
-142,622
-10% -$32.5M 1.76% 6
2025
Q3
$347M Buy
1,496,870
+138,316
+10% +$28.2M 1.9% 5
2025
Q2
$252M Buy
1,358,554
+549,513
+68% +$102M 1.3% 6
2025
Q1
$170M Sell
809,041
-9,367
-1% -$1.82M 0.88% 28
2024
Q4
$145M Sell
818,408
-99,362
-11% -$18.3M 0.7% 39
2024
Q3
$181M Sell
917,770
-11,677
-1% -$2.18M 0.81% 28
2024
Q2
$159M Sell
929,447
-45,255
-5% -$7.5M 0.73% 39
2024
Q1
$177M Sell
974,702
-145,431
-13% -$25.1M 0.79% 29
2023
Q4
$174M Sell
1,120,133
-57,875
-5% -$8.44M 0.79% 22
2023
Q3
$176M Sell
1,178,008
-101,108
-8% -$14.8M 1.12% 15
2023
Q2
$172M Sell
1,279,116
-61,107
-5% -$8.96M 1% 18
2023
Q1
$214M Sell
1,340,223
-25,273
-2% -$3.86M 1.27% 8
2022
Q4
$221M Sell
1,365,496
-113,652
-8% -$17.4M 1.32% 4
2022
Q3
$199M Buy
1,479,148
+55,264
+4% +$7.93M 1.3% 5
2022
Q2
$218M Sell
1,423,884
-151,632
-10% -$23.2M 1.28% 7
2022
Q1
$255M Sell
1,575,516
-102,975
-6% -$15M 1.25% 10
2021
Q4
$227M Sell
1,678,491
-81,683
-5% -$9.65M 1.15% 12
2021
Q3
$190M Sell
1,760,174
-20,095
-1% -$2.3M 1.05% 17
2021
Q2
$201M Sell
1,780,269
-284,206
-14% -$32M 1.08% 13
2021
Q1
$223M Sell
2,064,475
-84,556
-4% -$9.04M 1.05% 17
2020
Q4
$230M Buy
2,149,031
+58,632
+3% +$5.63M 1.06% 22
2020
Q3
$183M Sell
2,090,399
-9,042
-0.4% -$851K 0.91% 26
2020
Q2
$206M Sell
2,099,441
-59,994
-3% -$5.28M 1.06% 19
2020
Q1
$165M Buy
2,159,435
+385,517
+22% +$32.8M 1% 28
2019
Q4
$157M Buy
1,773,918
+209,886
+13% +$17.4M 0.68% 48
2019
Q3
$118M Sell
1,564,032
-22,874
-1% -$1.57M 0.54% 75
2019
Q2
$115M Buy
1,586,906
+21,587
+1% +$1.7M 0.52% 80
2019
Q1
$126M Buy
1,565,319
+114,693
+8% +$9.38M 0.55% 73
2018
Q4
$134M Sell
1,450,626
-177,423
-11% -$15.6M 0.62% 60
2018
Q3
$154M Buy
1,628,049
+52,463
+3% +$4.98M 0.58% 64
2018
Q2
$146K Sell
1,575,586
-910,398
-37% -$88.9M 0.45% 68
2018
Q1
$235M Sell
2,485,984
-4,588,115
-65% -$504M 0.83% 37
2017
Q4
$684M Sell
7,074,099
-790,991
-10% -$74.5M 2.26% 4
2017
Q3
$699M Sell
7,865,090
-496,620
-6% -$37.8M 2.34% 3
2017
Q2
$606M Buy
8,361,710
+628,431
+8% +$42.2M 2.05% 3
2017
Q1
$504M Buy
7,733,279
+979,876
+15% +$61.6M 1.68% 4
2016
Q4
$423M Sell
6,753,403
-82,718
-1% -$5.05M 1.59% 8
2016
Q3
$431M Buy
6,836,121
+590,275
+9% +$38.2M 1.61% 10
2016
Q2
$387M Sell
6,245,846
-2,367,620
-27% -$144M 1.45% 14
2016
Q1
$492M Sell
8,613,466
-1,896,422
-18% -$106M 1.86% 7
2015
Q4
$623M Buy
10,509,888
+2,972,241
+39% +$171M 2.46% 2
2015
Q3
$410M Sell
7,537,647
-197,296
-3% -$12.8M 1.59% 13
2015
Q2
$520M Buy
7,734,943
+1,558,297
+25% +$102M 1.92% 8
2015
Q1
$362M Buy
6,176,646
+802,865
+15% +$48.5M 1.35% 18
2014
Q4
$352M Sell
5,373,781
-41,884
-0.8% -$2.64M 1.27% 19
2014
Q3
$313M Buy
5,415,665
+64,551
+1% +$3.58M 1.22% 19
2014
Q2
$302M Buy
5,351,114
+122,402
+2% +$6.42M 1.18% 22
2014
Q1
$269M Buy
5,228,712
+86,142
+2% +$4.35M 1.08% 24
2013
Q4
$272M Sell
5,142,570
-217,341
-4% -$10.7M 1.15% 19
2013
Q3
$240M Sell
5,359,911
-1,512,585
-22% -$67M 1.07% 20
2013
Q2
$284M Buy
+6,872,496
New +$301M 1.42% 13

Other funds holding ABBV

Epoch Investment Partners's ABBV Position: Q1 2026 in Review

Epoch Investment Partners increased its AbbVie (ABBV) stake by 11% in Q1 2026, buying an estimated $33.7M and bringing the position to 1,506,142 shares worth $328M. The position accounts for 1.98% of the portfolio, ranked #2.

Epoch Investment Partners first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $699M in Q3 2017. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Epoch Investment Partners held 1,506,142 shares of AbbVie worth $328M as of Q1 2026.
  • Epoch Investment Partners bought 151,894 AbbVie shares in Q1 2026, an estimated $33.7M.
  • AbbVie made up 1.98% of Epoch Investment Partners's portfolio in Q1 2026, its #2 holding.
  • Epoch Investment Partners first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Epoch Investment Partners's AbbVie position peaked at $699M in Q3 2017.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Epoch Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.